Mallinckrodt Institute of Radiology, Washington University St. Louis, Missouri.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
J Nucl Med. 2021 Jan;62(1):6-14. doi: 10.2967/jnumed.120.253450.
The Society of Nuclear Medicine and Molecular Imaging created the Value Initiative in 2017 as a major component of its strategic plan to further demonstrate the value of molecular imaging and molecularly targeted radiopharmaceutical therapy to patients, physicians, payers, and funding agencies. The research and discovery domain, 1 of 5 under the Value Initiative, has a goal of advancing the research and development of diagnostic and therapeutic nuclear medicine. Research and discovery efforts and achievements are essential to ensure a bright future for NM and to translate science to practice. Given the remarkable progress in the field, leaders from the research and discovery domain and society councils identified 5 broad areas of opportunity with potential for substantive growth and clinical impact. This article discusses these 5 growth areas, identifying specific areas of particularly high importance for future study and development. As there was an understanding that goals should be both visionary yet achievable, this effort was called the Mars shot for nuclear medicine.
核医学与分子影像学会于 2017 年成立了价值倡议，作为其战略计划的重要组成部分，旨在进一步向患者、医生、支付方和资助机构展示分子影像和分子靶向放射性药物治疗的价值。该倡议下的五个领域之一的研究与发现领域，旨在推进诊断和治疗核医学的研究与开发。研究与发现工作和成果对于确保核医学的光明未来以及将科学转化为实践至关重要。鉴于该领域的显著进展，研究与发现领域和学会理事会的领导者确定了 5 个具有潜在重大增长和临床影响的广泛机会领域。本文讨论了这 5 个增长领域，并确定了未来研究和发展特别重要的具体领域。由于人们明白目标应该既具有远见又可实现，因此这项工作被称为核医学的“火星计划”。
